Brief: Euroapi And Abolis Biotechnologies Enter Into Partnership
Oct 23 (Reuters) - Euroapi SA EAPI.PA: ABOLIS BIOTECHNOLOGIES AND EUROAPI ENTER INTO PARTNERSHIP AS PART OF « IMPORTANT PROJECT OF COMMON EUROPEAN INTEREST » (IPCEI) IN FIELD OF HEALTHCARE, MED4CURE PROGRAM INCLUDES PUBLIC SUPPORT OF UP TO EUR 140 MILLION UNDER FRANCE 2030 Source text: ID:nBw6VXm2Xa Further company coverage: EAPI.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))